Source: 4-traders

Distributed Bio: Distributed Bio : Inc and Good Therapeutics, Inc. Announce Multi-Target Collaboration

(marketscreener.com) Distributed Bio, the global leader in computational optimization of fully human monoclonal antibody libraries, today announced a multi-target partnership with Good Therapeutics Inc. Distributed Bio will use its proprietary SuperHuman antibody library platform to discover therapeutic ready...http://www.marketscreener.com/news/Distributed-Bio-Inc-and-Good-Therapeutics-Inc-Announce-Multi-Target-Collaboration--27742101/?utm_medium=RSS&utm_content=20181212

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Jacob Glanville's photo - Chairman & CEO of Distributed Bio

Chairman & CEO

Jacob Glanville

CEO Approval Rating

90/100

Read more